Research Topics
Species | Jaclyn BiegelSummaryAffiliation: University of Pennsylvania Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomasMargaret J Dougherty
The Children s Hospital of Philadelphia, Room 1002 Abramson Research Building, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA
Neuro Oncol 12:621-30. 2010..BRAF mutations constitute a major genetic alteration in this histologic group of pediatric brain tumors and may serve as a molecular target for biologically based inhibitors...
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumorsJ A Biegel
The Children s Hospital of Philadelphia, and Department of Pediatrics, University of Pennsylvania School of Medicine, 19104, USA
Cancer Res 59:74-9. 1999..These studies suggest that INI1 is a tumor suppressor gene involved in rhabdoid tumors of the brain, kidney, and other extrarenal sites...
Molecular genetics of atypical teratoid/rhabdoid tumorJaclyn A Biegel
Division of Human Genetics, Department of Pediatrics, The Children s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Neurosurg Focus 20:E11. 2006..The complex is recruited to promoters of a large variety of genes involved in cell signaling, growth, and differentiation. This review summarizes what is currently known regarding the molecular genetics of RTs...
Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumorsJaclyn A Biegel
Division of Human Genetics and Department of Pathology, The Children s Hospital of Philadelphia, Pennsylvania 19104, USA
Clin Cancer Res 8:3461-7. 2002..The majority of rhabdoid tumors from all sites contained deletions and/or mutations of the INI1 gene. Specific mutations were nonrandomly associated with anatomical site...
Molecular analysis of pediatric brain tumorsJaclyn A Biegel
Division of Human Genetics, Department of Pediatrics, University of Pennsylvania School of Medicine, The Children s Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA
Curr Oncol Rep 6:445-52. 2004..Advances in this area will depend on the ability to identify new disease genes, validate prognostic markers, and develop biologically based therapeutic strategies to tailor treatment...
Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous systemJ A Biegel
Division of Human Genetics and Molecular Biology, The Children s Hospital of Philadelphia, Pennsylvania 19104, USA
Clin Cancer Res 6:2759-63. 2000..Detection of these mutations suggests that the child has an AT/RT, rather than a MB/PNET, a finding with important prognostic value...
Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumorJ A Biegel
Division of Human Genetics, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Genes Chromosomes Cancer 28:31-7. 2000..We propose that this germline INI1 mutation predisposed the child to the development of both malignancies. These findings lend support to the hypothesis that rhabdoid tumors in all sites have a common genetic etiology...
Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasmsAlexander R Judkins
Department of Pathology, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Am J Surg Pathol 28:644-50. 2004..INI1 immunostaining may have particular utility in the analysis of tumors with indeterminate histologic features or atypical immunophenotypic profiles...
Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumorsKatherine W Eaton
Division of Human Genetics, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Pediatr Blood Cancer 56:7-15. 2011..However, these studies were limited by case selection and an inability to detect intragenic deletions and duplications...
Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomasPortia A Kreiger
Department of Pathology and Laboratory Medicine, The Children s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Mod Pathol 22:142-50. 2009..Whether these undifferentiated sarcomas represent a clinicopathologic entity distinct from classic malignant rhabdoid tumor requires further investigation...
High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumorEric M Jackson
Department of Neurosurgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Hum Genet 122:117-27. 2007..2. These are the first reported cases in which an association has been established between recurrent, interstitial deletions mediated by LCRs in 22q11.2 and a predisposition to cancer...
Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumorsEric M Jackson
Department of Neurosurgery and Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Clin Cancer Res 15:1923-30. 2009....
No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumorsFan Zhang
Division of Human Genetics and Molecular Biology, The Children s Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA
Genes Chromosomes Cancer 34:398-405. 2002..One tumor demonstrated a potential mutation in the promoter region, but further studies are required for determining its functional significance...
Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumorsAndrew C Hoot
Department of Pathology, Children s Hospital of Philadelphia and The University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Am J Surg Pathol 28:1485-91. 2004....
The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumorsJaclyn A Biegel
Department of Pediatrics, Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Cancer Res 62:323-8. 2002..Drs. Malcolm Smith, Jaclyn Biegel, and Roger Packer hosted the meeting. There were 22 participants from 14 institutions...
INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinomaAlexander R Judkins
Department of Pathology, University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia, 3615 Civic Center Blvd, Philadelphia, PA 19104, USA
J Neuropathol Exp Neurol 64:391-7. 2005..This expression pattern seems to better define the 2 groups of tumors than does light or electron microscopy, routine immunohistochemistry, or cytogenetic analysis alone...
Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion geneAngela J Sievert
Division of Oncology, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
Brain Pathol 19:449-58. 2009..Further studies are required to determine the role of this fusion gene in downstream MAPK signaling and its role in development of pediatric low-grade astrocytomas...
Early molecular detection of central nervous system relapse in a child with systemic anaplastic large cell lymphoma: case report and review of the literatureGregory Armstrong
Division of Hematology and Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4399, USA
Pediatr Blood Cancer 44:400-6. 2005..This case demonstrates the feasibility of detecting ALCL in paucicellular CSF specimens and suggests that even low CSF involvement can herald massive parenchymal disease...
High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous systemTheodore Nicolaides
Department of Pediatrics, University of California San Francisco School of Medicine, 505 Parnassus Avenue, M649, Box 0106, San Francisco, CA 94143, USA
J Neurooncol 98:117-23. 2010..Two of nine patients treated for AT/RT at our institution with high dose chemotherapy and autologous bone marrow transplant are long-term survivors, suggesting that a subset of patients can be cured with this approach...
Atypical teratoid/rhabdoid tumor in a patient with Beckwith-Wiedemann syndromeEric M Jackson
Department of Neurosurgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Am J Med Genet A 143:1767-70. 2007..These results suggest that, despite an underlying cancer predisposition, the occurrence of BWS and AT/RT in this patient may be unrelated...
Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6Leslie J Raffini
Division of Oncology, Joseph Stokes, Jr Research Institute, Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
Proc Natl Acad Sci U S A 99:4568-73. 2002..The sequences in these three cases show additional MLL genomic breakpoint heterogeneity. Each breakpoint junction suggests nonhomologous end joining and is consistent with DNA damage and repair. CDK6-MLL is a new fusion of both genes...
Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imagingRobert G Whitmore
Department of Neurosurgery, The Children s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
J Neurosurg 107:600-9. 2007..The aim of this study was to use perfusion weighted MR imaging to predict tumor grade and cytogenetic profile in oligodendroglial neoplasms...
Surgical treatment of a clival-C2 atypical teratoid/rhabdoid tumorGregory G Heuer
Department of Neurosurgery, Children s Hospital of Philadelphia, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104 4399, USA
J Neurosurg Pediatr 5:75-9. 2010..The conus tumor was resected and found to be consistent with the primary tumor. Several months later the patient presented with disseminated intrathecal disease and ultimately died 42 months after the initial resection...
ZNF238 is expressed in postmitotic brain cells and inhibits brain tumor growthValerie M Tatard
The Wistar Institute, Philadelphia, Pennsylvania, USA
Cancer Res 70:1236-46. 2010..ZNF238 is thus a novel brain tumor suppressor and its reactivation in tumors could open a novel anticancer strategy...
High-resolution detection and mapping of genomic DNA alterations in neuroblastomaYael P Mosse
Division of Oncology, Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
Genes Chromosomes Cancer 43:390-403. 2005..Taking all of this together indicates that aCGH can accurately measure CNAs in the neuroblastoma genome and facilitate gene discovery efforts by high-throughput refinement of candidate loci...
Chromophobe renal cell carcinoma in a pediatric living-related kidney transplant recipientAndres J Greco
Department of Surgery, The Children's Hospital of Philadelphia, PA 19104, USA
Am J Kidney Dis 45:e105-8. 2005..The patient was found to have cat-scratch disease. A renal cell carcinoma should be considered in the differential diagnosis of a pediatric recipient of an adult kidney with an incidental finding of a tumor in the graft...
Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidyEdward F Attiyeh
Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, and Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania 19104 4318, USA
Genome Res 19:276-83. 2009....
Parental heat exposure and risk of childhood brain tumor: a Children's Oncology Group studyGreta R Bunin
Division of Oncology, Children s Hospital of Philadelphia, PA 19104, USA
Am J Epidemiol 164:222-31. 2006..4, 95% CI: 1.2, 9.7, and odds ratio = 2.1, 95% CI: 1.1, 4.3, respectively). This new observation regarding paternal exposure to heat just prior to the index pregnancy deserves consideration in future animal and human studies of MB/PNET...
TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasmsKim E Nichols
Department of Pediatric Oncology, Children s Hospital of Philadelphia, PA, USA
J Clin Oncol 21:4505-9. 2003..To clarify whether host genetic factors contribute to secondary tumorigenesis, we performed mutational analyses of the TP53, BRCA1, and BRCA2 tumor suppressor genes in a cohort of 44 HD patients developing one or more SMN...
Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instabilityElizabeth S McKenna
Department of Pediatric Oncology, Dana Farber Cancer Institute, Division of Hematology Oncology, Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
Mol Cell Biol 28:6223-33. 2008....
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformationMichael S Isakoff
Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 102:17745-50. 2005..Further, conditional mouse models demonstrate that inactivation of p16Ink4a or Rb (retinoblastoma) does not accelerate tumor formation in Snf5 conditional mice, whereas mutation of p53 leads to a dramatic acceleration of tumor formation...
Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registryJoanne M Hilden
Department of Pediatric Hematology Oncology, The Children s Hospital, The Cleveland Clinic, 9500 Euclid Avenue, Desk S20, Cleveland, OH 44195, USA
J Clin Oncol 22:2877-84. 2004..The poor outcome with conventional infant brain tumor therapy has resulted in a lack of clear treatment guidelines. A registry has been established to create an outcomes database and to facilitate biology studies for this tumor...
Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature reviewLars M Wagner
Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
Pediatr Dev Pathol 10:409-15. 2007..Important similarities and differences between hepatoblastoma and rhabdoid tumors are reviewed, and suggestions are offered to help distinguish these 2 tumor types...
Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshopRoger J Packer
Department of Neurology, Children s National Medical Center, The George Washington University Medical Center, Washington, DC 20010, USA
J Pediatr Hematol Oncol 24:337-42. 2002..Therapeutic approached have included surgery, chemotherapy, and radiotherapy. Prospective clinical trials are needed for children with AT/RTs...
INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomasArie Perry
Department of Pathology, Washington University School of Medicine, St Louis, MO 63001 1093, USA
Mod Pathol 18:951-8. 2005..Therefore, we conclude that INI1 immunohistochemistry is a relatively simple, sensitive, and specific technique for distinguishing malignant rhabdoid tumor and atypical teratoid/rhabdoid tumor from composite rhabdoid tumor...
Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adultsJack Raisanen
Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9073, USA
Brain Pathol 15:23-8. 2005..These molecular findings confirm the occurrence of AT/RTs in adults. Although rare, AT/RT should be considered in the differential diagnosis of poorly differentiated intracranial tumors in adults...
Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutationKristin Janson
Department of Radiation Oncology, Tulane University, New Orleans, Los Angeles, USA
Pediatr Blood Cancer 47:279-84. 2006..There may be a developmental window in which most rhabdoid tumors occur. This family highlights the importance of mutation analysis in all patients with a suspected rhabdoid tumor...
Atypical teratoid/rhabdoid tumor evolving from an optic pathway ganglioglioma: case studyJeffrey C Allen
Department of Neurology, New York University School of Medicine, New York, NY 10016, USA
Neuro Oncol 8:79-82. 2006..This report is the first to describe progression of a ganglioglioma to atypical teratoid/rhabdoid tumor...
Mutation of the INI1 gene in composite rhabdoid tumor of the endometriumLudvik R Donner
Department of Pathology, Scott and White Memorial Hospital and Clinic, Scott, Sherwood and Brindley Foundation, Texas A and M University Health Science Center College of Medicine, Temple, TX 76508, USA
Hum Pathol 38:935-9. 2007..Our results demonstrate that deletions and mutations of the INI1 gene can occur also in rare composite rhabdoid tumors of adulthood. Further studies are necessary, however, to determine the prognostic significance of this finding...
Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literatureElena L Zarovnaya
Department of Pathology, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA
J Neurooncol 84:49-55. 2007..An unrestricted autopsy was performed. To our knowledge, this is the first case of a spinal atypical teratoid/rhabdoid tumor in an adult fully documented with molecular, immunohistochemical, cytogenetic and autopsy findings...
Atypical teratoid/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytomaGeeta Chacko
Division of Neuropathology, Department of Neurological Sciences, Christian Medical College, Vellore, India
J Neurooncol 84:217-22. 2007..We speculate that the PXA was a quiescent tumor and that the secondary genetic alterations, including inactivation of the INI1 gene led to clinical progression...
Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patientsEdward Pan
University of California San Francisco, San Francisco, California, USA
Clin Cancer Res 11:4733-40. 2005..i(17)(q10) was a significant independent negative prognostic factor. Infant medulloblastomas may be a distinct genetic subset from those of older patients...
Prediction of central nervous system embryonal tumour outcome based on gene expressionScott L Pomeroy
Division of Neuroscience, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Nature 415:436-42. 2002..We show further that the clinical outcome of children with medulloblastomas is highly predictable on the basis of the gene expression profiles of their tumours at diagnosis...
Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumorsYushui Wu
Department of Oncology, University of Calgary, the Tom Baker Cancer Centre, and the Clark H Smith Brain Tumour Research Centre, Calgary, Alberta, Canada
Clin Cancer Res 14:1218-27. 2008..The purpose of this study was to evaluate the therapeutic potential of two oncolytic viruses, myxoma virus (MV) and an attenuated vesicular stomatitis virus (VSV(DeltaM51)), in experimental models of human rhabdoid tumor...
Research Grants
- GENETICS OF PEDIATRIC RHABDOID TUMORSJaclyn Biegel; Fiscal Year: 1999..Identification of the rhabdoid tumor gene will be a major contribution towards the design of sensitive diagnostic assays, and improved treatment protocols. ..
- GENETICS OF PEDIATRIC RHABDOID TUMORSJaclyn Biegel; Fiscal Year: 2009..Understanding the mechanisms by which INI1 is inactivated will be important for treatment stratification, and ultimately designing biologically based therapeutic strategies for patients. ..
- GENETICS OF PEDIATRIC RHABDOID TUMORSJaclyn Biegel; Fiscal Year: 2005....
- GENETICS OF PEDIATRIC RHABDOID TUMORSJaclyn A Biegel; Fiscal Year: 2010..Understanding the mechanisms by which INI1 is inactivated will be important for treatment stratification, and ultimately designing biologically based therapeutic strategies for patients. ..
